Along with the released RSL3, a GPX4‐targeted FINs inhibits the adaptive upregulation of the antioxidant enzyme GPX4, thereby reducing potent tumor radioresistance and enhancing ferroptosis to suppress tumor growth. The gene discussed is GPX4; the disease is neoplasm.